{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:43Z","timestamp":1793278303964,"version":"4.5.0"},"reference-count":14,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Large cell transformation (LCT) in mycosis fungoides (MF) is generally associated with an aggressive clinical course and poor survival, requiring aggressive therapeutic approach. However, a proportion of cases may follow an indolent clinical course. To identify prognostic factors, we analyzed the prognostic relevance of clinical, histologic, and immunophenotypical features in a large cohort of transformed MF patients, including 75 patients with only skin lesions, 19 patients with LCT in skin and lymph nodes, and 6 patients with LCT in lymph nodes only. Multivariate analysis of the total group showed that CD30 negativity, folliculotropic MF, extent of skin lesions and extracutaneous transformation were associated with reduced disease-specific survival (DSS) and, except for CD30 negativity and folliculotropic MF, also overall survival. In a multivariate analysis of 75 patients with only skin lesions at the time of LCT, CD30 negativity, folliculotropic MF and extent of skin lesions were independent parameters for both DSS and overall survival. Using the most discriminating parameters as a prognostic index, in both study groups differences in DSS between patients with 0-1 unfavorable prognostic factor(s) and \u2265 2 unfavorable prognostic factors were statistically significant (P &lt; .001). This prognostic index may be helpful in predicting prognosis and selecting the most appropriate treatment in patients with transformed MF.<\/jats:p>","DOI":"10.1182\/blood-2011-08-376319","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T05:32:44Z","timestamp":1323754364000},"page":"1643-1649","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":199,"title":["Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases"],"prefix":"10.1182","volume":"119","author":[{"given":"Marchina F.","family":"Benner","sequence":"first","affiliation":[{"name":"Departments of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty M.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Pathology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"31","key":"2019111811230663200_B1","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal.","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111811230663200_B2","first-page":"504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.","volume":"136","author":"van Doorn Van Haselen","year":"2000","journal-title":"Arch Dermatol"},{"issue":"4","key":"2019111811230663200_B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hon.2900080406","article-title":"Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process.","volume":"8","author":"Greer","year":"1990","journal-title":"Hematol Oncol"},{"issue":"2","key":"2019111811230663200_B4","first-page":"265","article-title":"Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.","volume":"132","author":"Salhany","year":"1988","journal-title":"Am J Pathol"},{"issue":"8","key":"2019111811230663200_B5","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","article-title":"Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation.","volume":"112","author":"Arulogun","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111811230663200_B6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2007.08008.x","article-title":"Transformed mycosis fungoides: clinicopathological features and outcome.","volume":"157","author":"Barberio","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019111811230663200_B7","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis.","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111811230663200_B8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JCO.1987.5.2.208","article-title":"Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.","volume":"5","author":"Dmitrovsky","year":"1987","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111811230663200_B9","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases.","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"issue":"6 Pt 1","key":"2019111811230663200_B10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/Sezary syndrome.","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2019111811230663200_B11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(19810101)47:1<119::AID-CNCR2820470120>3.0.CO;2-F","article-title":"Prognostic significance of cytomorphology in the cutaneous T-cell lymphomas.","volume":"47","author":"Vonderheid","year":"1981","journal-title":"Cancer"},{"issue":"6","key":"2019111811230663200_B12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111811230663200_B13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-199206000-00002","article-title":"Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.","volume":"16","author":"Cerroni","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"2019111811230663200_B14","unstructured":"National Comprehensive Cancer Network\n          National Comprehensive Cancer Network clinical practice guidelines version 3.2011.\n          Accessed May 18, 2011\n          \n            http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/nhl.pdf"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1643\/1355877\/zh800712001643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1643\/1355877\/zh800712001643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:36:18Z","timestamp":1574094978000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/7\/1643\/30100\/Prognostic-factors-in-transformed-mycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-08-376319","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}